DNA treatment cuts bad cholesterol by nearly 50% without statins
Friday, September 11, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Researchers have designed a new DNA-based treatment that targets PCSK9, a protein closely tied to high LDL cholesterol and atherosclerosis. Their most effective molecule reduced PCSK9 protein by 87% in human liver cells and lowered cholesterol by 47% in genetically modified mice after a single injection. (via Science Daily)
Read the Full StoryThis article will expire in 29 days.
In the News...
View All Recent News
- One sugary drink a day linked to more than double the risk of stomach cancer
- DNA treatment cuts bad cholesterol by nearly 50% without statins
- UCLA scientists turn cord blood into powerful cancer-fighting T cells
- Eating only 8 hours a day may help control Type 1 diabetes
- Scientists discover the human heart can regrow muscle after a heart attack
- Scientists find signs of extreme aging and youth in the same 117-year-old
- Study of 1.9 million people finds a striking link between ADHD and gut problems
- Your next prescription could be treating a side effect from the last one
- Too much light at night may quietly reshape your heart
- Caffeine may flip an ancient cellular switch linked to slower aging
- Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
- Scientists find a bone-building switch that could fight osteoporosis
- Early statin use linked to 15% lower dementia risk
- MIT scientists develop injectable “mini livers” that work inside the body
- Scientists find a new weakness in treatment-resistant prostate cancer
- Your gut microbiome may be more contagious than scientists thought
- Cialis linked to higher glaucoma risk in large study
- Scientists discover a hidden immune signal that helps spinal cords regrow
- Scientists say love follows hidden mathematical rules
- Cancer cases could surge 67% worldwide by 2050